Randomized, Double Blind, Multicenter Study of the Safety and Efficacy of Valdecoxib 40 mg Once Daily Compared With Diclofenac 75 mg Twice Daily in Acute Low Back Pain
Clinical trial NCT00649610 · COMPLETED
Trial details
- NCT number
- NCT00649610
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-01
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.